Raymond Lipicky, MD
Raymond John Lipicky, MD is the Director of LIPICKY, LLC (a consulting company) having retired (March 2002, after 21 years of service) from the U.S Food and Drug Administration (FDA) where he held the position of Director, Division of Cardio-Renal Drug Products, Office of Drug Evaluation I, Center for Drug Evaluation and Research. Previously, he was on the faculty of University of Cincinnati, College of Medicine (for 14 years) where he held the positions of Professor of Pharmacology and Professor of Medicine and Director, Division of Clinical Pharmacology at the time he joined FDA. He is a graduate of the University of Cincinnati College of Medicine, trained in Internal Medicine and Cardiology. He also had an appointment as Visiting Scientist at the Marine Biological Laboratory (Woods Hole, MA) where, for about 30 years, he had a summer laboratory pursuing an interest in drug effects on electrically-excitable membranes, although his laboratory is no longer active. He has served on numerous DMCs, and was the Chairman of the DMC for the dronderone ATHENA study.